Literature DB >> 15161741

Human pancreatic duct cells exert tissue factor-dependent procoagulant activity: relevance to islet transplantation.

Claire Beuneu1, Olivier Vosters, Babak Movahedi, Myriam Remmelink, Isabelle Salmon, Daniel Pipeleers, Olivier Pradier, Michel Goldman, Valérie Verhasselt.   

Abstract

Activation of the coagulation cascade contributes to early graft loss and intraportal thrombotic events in clinical islet transplantation. Although these complications were shown to be related to the presence of tissue factor in human islet preparations, the contribution of duct cells, which represent a major contaminant of clinical islet isolates, has not been specified so far. Herein, we used flow cytometry, immunohistochemistry, RT-PCR, and functional coagulation assays to demonstrate that duct cells exert a potent factor VII-dependent procoagulant activity related to their expression of tissue factor. Both the classical membrane-bound and the recently described soluble form of tissue factor were shown to be synthesized by duct cells. We conclude that contaminating duct cells contribute to early beta-cell damage after islet transplantation through their involvement in tissue factor-mediated thrombotic and inflammatory events.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15161741     DOI: 10.2337/diabetes.53.6.1407

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  13 in total

1.  Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells.

Authors:  Olivia G Kelly; Man Yin Chan; Laura A Martinson; Kuniko Kadoya; Traci M Ostertag; Kelly G Ross; Mike Richardson; Melissa K Carpenter; Kevin A D'Amour; Evert Kroon; Mark Moorman; Emmanuel E Baetge; Anne G Bang
Journal:  Nat Biotechnol       Date:  2011-07-31       Impact factor: 54.908

2.  Plasma GAD65, a Marker for Early β-Cell Loss After Intraportal Islet Cell Transplantation in Diabetic Patients.

Authors:  Zhidong Ling; Pieter De Pauw; Daniel Jacobs-Tulleneers-Thevissen; Rui Mao; Pieter Gillard; Christiane S Hampe; Geert A Martens; Peter In't Veld; Åke Lernmark; Bart Keymeulen; Frans Gorus; Daniel Pipeleers
Journal:  J Clin Endocrinol Metab       Date:  2015-03-27       Impact factor: 5.958

3.  Human islet cell implants in a nude rat model of diabetes survive better in omentum than in liver with a positive influence of beta cell number and purity.

Authors:  D Jacobs-Tulleneers-Thevissen; K Bartholomeus; K Suenens; I Vermeulen; Z Ling; K H Hellemans; P In't Veld; M Pipeleers-Marichal; D Pipeleers
Journal:  Diabetologia       Date:  2010-04-16       Impact factor: 10.122

4.  Tissue factor inflammatory response regulated by promoter genotype and p38 MAPK in neonatal vs. adult microvascular endothelial cells.

Authors:  Jeffrey S Buzby; Shirley A Williams; Karen L Imfeld; Thomas J Kunicki; Diane J Nugent
Journal:  Inflamm Res       Date:  2014-01-03       Impact factor: 4.575

5.  Sustained function of alginate-encapsulated human islet cell implants in the peritoneal cavity of mice leading to a pilot study in a type 1 diabetic patient.

Authors:  D Jacobs-Tulleneers-Thevissen; M Chintinne; Z Ling; P Gillard; L Schoonjans; G Delvaux; B L Strand; F Gorus; B Keymeulen; D Pipeleers
Journal:  Diabetologia       Date:  2013-04-26       Impact factor: 10.122

6.  N-Acetylcysteine derivative inhibits procoagulant activity of human islet cells.

Authors:  C Beuneu; O Vosters; Z Ling; D Pipeleers; O Pradier; M Goldman; V Verhasselt
Journal:  Diabetologia       Date:  2006-12-20       Impact factor: 10.122

Review 7.  Liver cell transplantation for Crigler-Najjar syndrome type I: update and perspectives.

Authors:  Philippe-A Lysy; Mustapha Najimi; Xavier Stephenne; Annick Bourgois; Francoise Smets; Etienne-M Sokal
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

8.  Characterization of pancreatic ductal cells in human islet preparations.

Authors:  Hirohito Ichii; Atsushi Miki; Toshiyuki Yamamoto; Ruth D Molano; Scott Barker; Atsuyoshi Mita; Rayner Rodriguez-Diaz; Dagmar Klein; Ricardo Pastori; Rodolfo Alejandro; Luca Inverardi; Antonello Pileggi; Camillo Ricordi
Journal:  Lab Invest       Date:  2008-09-08       Impact factor: 5.662

9.  Bivalirudin in combination with heparin to control mesenchymal cell procoagulant activity.

Authors:  Xavier Stephenne; Emanuele Nicastro; Stephane Eeckhoudt; Cedric Hermans; Omar Nyabi; Catherine Lombard; Mustapha Najimi; Etienne Sokal
Journal:  PLoS One       Date:  2012-08-10       Impact factor: 3.240

10.  Pancreatic duct cells in human islet cell preparations are a source of angiogenic cytokines interleukin-8 and vascular endothelial growth factor.

Authors:  Babak Movahedi; Conny Gysemans; Daniel Jacobs-Tulleneers-Thevissen; Chantal Mathieu; Daniel Pipeleers
Journal:  Diabetes       Date:  2008-05-20       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.